Long-read genome sequencing offers a more precise method for diagnosing rare genetic disorders by reading DNA segments up to 20,000 building blocks long, according to researchers at Radboud university medical center. Published in the New England Journal of Medicine, the study indicates this technology can replace 15 standard diagnostic tests, identifying genetic abnormalities and DNA modifications that traditional fragment-based sequencing often misses.
How does long-read sequencing improve diagnostic accuracy?
Current diagnostic standards typically rely on short-read sequencing, which breaks DNA into fragments of approximately 300 building blocks. According to Professor of Translational Genomics Lisenka Vissers, reassembling these short fragments is like solving a difficult jigsaw puzzle. By shifting to long-read sequencing, which processes segments of up to 20,000 building blocks, clinicians can assemble the genetic “puzzle” with significantly larger pieces, leading to a more complete and accurate DNA map.
Up to 400 million people globally live with a rare disease, yet a diagnosis often takes years to achieve. Researchers suggest that moving to a single, comprehensive test could drastically shorten this diagnostic odyssey.
Can one test replace multiple diagnostic procedures?
Yes, the new method functions as a “two-in-one” diagnostic tool. Professor of Genome Bioinformatics Christian Gilissen reports that long-read sequencing captures DNA modifications—which switch genes on or off—simultaneously while reading the sequence itself. Traditional diagnostics require separate, specialized tests to identify these modifications. By consolidating these steps, the new approach increases diagnostic yield by three percent, according to the Radboudumc study.
What are the future implications for rare disease treatment?
The ability to detect complex, hard-to-find genetic abnormalities suggests that the number of successful diagnoses will continue to rise. Professor of Genomic Technologies Alexander Hoischen notes that as researchers link these newly identified complex abnormalities to specific clinical conditions, the medical community’s overall knowledge base expands. This data-driven growth is expected to facilitate earlier interventions for patients who previously remained undiagnosed.
For families seeking answers, participating in collaborative initiatives like the “Undiagnosed Hackathon” can be beneficial. Recent events in Nijmegen involving 150 specialists across Dutch university medical centers successfully used this long-read technology to secure five new diagnoses for participating families.
Frequently Asked Questions
What defines a rare disease?
A condition is classified as rare if it affects fewer than one in 2,000 people. Despite this classification, there are over 7,000 known types of rare diseases, 80% of which have a genetic origin.
Why is a genetic diagnosis important?
According to researchers, a definitive diagnosis provides clarity for families, offers insight into the progression of a condition, connects patients with support groups, and allows for informed risk assessment when planning for children.
How does long-read sequencing differ from standard tests?
Standard tests read DNA in small, 300-base-pair fragments. Long-read technology reads up to 20,000 base pairs at once, allowing for the detection of complex structural variations and epigenetic modifications that smaller fragments cannot capture.
Are you interested in the latest breakthroughs in genomic medicine? Subscribe to our newsletter for updates on diagnostic technology and rare disease research. If you found this article helpful, please share it with your network.
